Hirakata, Japan

Kazuko Ando


Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Hirakata, JP (1983 - 1984)
  • Osaka, JP (1985)

Company Filing History:


Years Active: 1983-1985

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kazuko Ando: Innovator in Anti-Tumor Agents

Introduction

Kazuko Ando is a notable inventor based in Hirakata, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-tumor agents. With a total of 3 patents to her name, her work has garnered attention for its potential impact on cancer treatment.

Latest Patents

Ando's latest patents include innovative compounds such as 2'-Deoxy-3',5'-di-O-alkylcarbonyl-5-fluorouridine derivatives. These derivatives are characterized by their strong anti-tumor activity coupled with weak toxicity. They are represented by a specific general formula, wherein R stands for an alkyl group, an alkoxy group, or a halogen atom. The preparation of these derivatives involves acylating a 2'-deoxy-3',5'-di-O-alkylcarbonyl-5-fluorouridine with corresponding benzoyl halides, making them useful as active ingredients for oral anti-tumor agents. Another significant patent involves new ester derivatives of alkoxybenzoyldeoxyfluorouridine, which also serve as active ingredients for anti-tumor agents.

Career Highlights

Kazuko Ando has worked with prominent companies in the pharmaceutical industry, including Funai Yakuhin Kogyo Co., Ltd. and Funai Kakuhin Kogyo Co., Ltd. Her experience in these organizations has contributed to her expertise in developing innovative pharmaceutical solutions.

Collaborations

Ando has collaborated with notable colleagues such as Setsuro Fujii and Bompei Yasui. These partnerships have likely enhanced her research and development efforts in the field of anti-tumor agents.

Conclusion

Kazuko Ando's contributions to the development of anti-tumor agents highlight her innovative spirit and dedication to improving cancer treatment. Her patents reflect a commitment to advancing pharmaceutical science and offer promising avenues for future research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…